(2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen

C45H73N9O18 — CID 162193619

IUPAC(2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen
SMILESCC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)[C@@H](O[C@@H](C)C(=O)NC)C1O.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)[C@@H](O[C@H](C)C(=O)NC)C1O.CC[C@H]1O[C@@H]2[C@H](Oc3nc(=O)c(C)cn32)C1O.CNC(=O)C(C)O.[H][H].[H][H]
InChIInChI=1S/2C15H23N3O6.C11H14N2O4.C4H9NO2.2H2/c2*1-5-9-10(19)11(23-8(3)13(21)16-4)14(24-9)18-6-7(2)12(20)17-15(18)22;1-3-6-7(14)8-10(16-6)13-4-5(2)9(15)12-11(13)17-8;1-3(6)4(7)5-2;;/h2*6,8-11,14,19H,5H2,1-4H3,(H,16,21)(H,17,20,22);4,6-8,10,14H,3H2,1-2H3;3,6H,1-2H3,(H,5,7);2*1H/t8-,9+,10?,11-,14+;8-,9-,10?,11+,14-;6-,7?,8-,10-;;;/m011.../s1
InChIKeyZQQNQGZOFYOKTA-BDPWRXRFSA-N
MW1028.12 g/mol
LogP-2.35
Rot. Bonds12

About (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen

(2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen (PubChem CID 162193619) has the molecular formula C45H73N9O18 and a molecular weight of 1028.12 g/mol. Its IUPAC name is (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen.

Molecular Properties

Compound Name(2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen
PubChem CID162193619
Molecular FormulaC45H73N9O18
Molecular Weight1028.12 g/mol
Exact Mass1027.51
IUPAC Name(2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen
SMILESCC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)[C@@H](O[C@@H](C)C(=O)NC)C1O.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)[C@@H](O[C@H](C)C(=O)NC)C1O.CC[C@H]1O[C@@H]2[C@H](Oc3nc(=O)c(C)cn32)C1O.CNC(=O)C(C)O.[H][H].[H][H]
InChIInChI=1S/2C15H23N3O6.C11H14N2O4.C4H9NO2.2H2/c2*1-5-9-10(19)11(23-8(3)13(21)16-4)14(24-9)18-6-7(2)12(20)17-15(18)22;1-3-6-7(14)8-10(16-6)13-4-5(2)9(15)12-11(13)17-8;1-3(6)4(7)5-2;;/h2*6,8-11,14,19H,5H2,1-4H3,(H,16,21)(H,17,20,22);4,6-8,10,14H,3H2,1-2H3;3,6H,1-2H3,(H,5,7);2*1H/t8-,9+,10?,11-,14+;8-,9-,10?,11+,14-;6-,7?,8-,10-;;;/m011.../s1
InChIKeyZQQNQGZOFYOKTA-BDPWRXRFSA-N
XLogP-2.35
TPSA368.21 Ų
H-Bond Donors9
H-Bond Acceptors22
Rotatable Bonds12
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001028.12
LogP ≤ 5-2.35
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1022

Analyze (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen?
The IUPAC name of (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen (CID 162193619) is (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen.
What is the SMILES notation for (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen?
The canonical SMILES for (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen is CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)[C@@H](O[C@@H](C)C(=O)NC)C1O.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)[C@@H](O[C@H](C)C(=O)NC)C1O.CC[C@H]1O[C@@H]2[C@H](Oc3nc(=O)c(C)cn32)C1O.CNC(=O)C(C)O.[H][H].[H][H].
What is the InChIKey of (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen?
The InChIKey is ZQQNQGZOFYOKTA-BDPWRXRFSA-N. The full InChI is InChI=1S/2C15H23N3O6.C11H14N2O4.C4H9NO2.2H2/c2*1-5-9-10(19)11(23-8(3)13(21)16-4)14(24-9)18-6-7(2)12(20)17-15(18)22;1-3-6-7(14)8-10(16-6)13-4-5(2)9(15)12-11(13)17-8;1-3(6)4(7)5-2;;/h2*6,8-11,14,19H,5H2,1-4H3,(H,16,21)(H,17,20,22);4,6-8,10,14H,3H2,1-2H3;3,6H,1-2H3,(H,5,7);2*1H/t8-,9+,10?,11-,14+;8-,9-,10?,11+,14-;6-,7?,8-,10-;;;/m011.../s1.
What are the key properties of (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen?
(2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen has a molecular weight of 1028.12 g/mol, XLogP of -2.35, 12 rotatable bonds, 9 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,4R,6R)-4-ethyl-5-hydroxy-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one;(2S)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;(2R)-2-[(2R,3S,5R)-5-ethyl-4-hydroxy-2-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-N-methylpropanamide;2-hydroxy-N-methylpropanamide;molecular hydrogen is sourced from PubChem (CID 162193619), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).